KURE
KraneShares MSCI All China Health Care Index ETF
1W: -1.5%
1M: -8.6%
3M: -6.1%
YTD: -4.4%
1Y: +11.0%
3Y: -15.9%
5Y: -48.6%
$16.25
-0.37 (-2.23%)
After Hours: $16.23 (-0.02, -0.09%)
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Weather
ETF-Level Metrics
AUM$79M
Holdings45
Top 10 Wt54.5%
Beta0.59
% Profitable52%
Coverage96%
Portfolio Valuation
P/E29.5
P/B5.2
P/S2.8
EV/EBITDA15.4
P/FCF35.7
PEG1.00
Profitability & Returns
Gross Margin32.2%
Net Margin9.2%
ROE17.9%
ROA10.2%
ROIC23.0%
Div Yield1.22%
Leverage & Liquidity
Debt/Equity0.21
Debt/Assets0.12
Net Debt/EBITDA-0.9x
Interest Cov36.0x
Current Ratio1.96
Quick Ratio1.66
Growth (YoY)
Revenue+18.9%
Net Income+23.8%
EPS+23.9%
FCF+48.6%
EBITDA+27.4%
Rev CAGR 3Y+48.9%
Quality Scores
Piotroski F6.2
Altman Z19.46
IS Quality73.8
IS Overall58.1
IS Value52.6
Median P/E21.1
Sector Breakdown
3 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 43 | 95.4% | 18.7 |
| Other | 5 | 3.8% | — |
| Consumer Defensive | 1 | 0.7% | -165.3 |
Smart Money Overlap
0 holdings with signalsNo holdings with active convergence signals
Showing 49 of 49 holdings
· Page 1 of 1
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | INNOVENT BIOLOGICS INC | 1801.HK | 8.43% | $6.7M | 645,000 | 107.7 | $142.1B | Healthcare |
| 2 | BEONE MEDICINES LTD-H | 6160.HK | 8.13% | $6.5M | 300,318 | 106.8 | $251.3B | Healthcare |
| 3 | WUXI BIOLOGICS CAYMAN INC | 2269.HK | 6.90% | $5.5M | 1,266,135 | 23.5 | $136.8B | Healthcare |
| 4 | WUXI APPTEC CO LTD-A | 603259.SS | 5.34% | $4.3M | 321,720 | 12.4 | $232.5B | Healthcare |
| 5 | AKESO INC | 9926.HK | 5.21% | $4.2M | 278,000 | -115.3 | $112.1B | Healthcare |
| 6 | JIANGSU HENGRUI PHARMACEUT-A | 600276.SS | 4.68% | $3.7M | 461,108 | 46.5 | $345.1B | Healthcare |
| 7 | SHENZHEN MINDRAY BIO-MEDIC-A | 300760.SZ | 4.51% | $3.6M | 144,555 | 23.3 | $202.9B | Healthcare |
| 8 | SINO BIOPHARMACEUTICAL | 1177.HK | 4.33% | $3.5M | 4,475,750 | 24.0 | $106.1B | Healthcare |
| 9 | CSPC PHARMACEUTICAL GROUP LT | 1093.HK | 3.60% | $2.9M | 2,500,889 | 22.6 | $97.0B | Healthcare |
| 10 | HANSOH PHARMACEUTICAL GROUP | 3692.HK | 3.33% | $2.7M | 638,000 | 34.5 | $187.1B | Healthcare |
| 11 | 3SBIO INC | 1530.HK | 2.91% | $2.3M | 801,500 | 19.9 | $52.7B | Healthcare |
| 12 | WUXI APPTEC CO LTD-H | 2359.HK | 2.89% | $2.3M | 167,584 | 12.4 | $320.7B | Healthcare |
| 13 | YUNNAN BAIYAO GROUP CO LTD-A | 000538.SZ | 2.30% | $1.8M | 224,023 | 18.9 | $98.8B | Healthcare |
| 14 | SHANGHAI UNITED IMAGING HE-A Private | 2.25% | $1.8M | 107,071 | — | — | — | |
| 15 | ZHANGZHOU PIENTZEHUANG PHA-A | 600436.SS | 2.18% | $1.7M | 76,434 | 38.1 | $93.0B | Healthcare |
| 16 | AIER EYE HOSPITAL GROUP CO-A | 300015.SZ | 2.16% | $1.7M | 1,176,763 | 27.5 | $90.1B | Healthcare |
| 17 | SINOPHARM GROUP CO-H | 1099.HK | 1.92% | $1.5M | 576,400 | 8.1 | $62.7B | Healthcare |
| 18 | SHENZHEN SALUBRIS PHARM-A | 002294.SZ | 1.52% | $1.2M | 145,065 | 94.6 | $63.6B | Healthcare |
| 19 | SICHUAN KELUN-BIOTECH BIOP-H Private | 1.48% | $1.2M | 21,400 | — | — | — | |
| 20 | HUADONG MEDICINE CO LTD-A | 000963.SZ | 1.43% | $1.1M | 221,041 | 16.1 | $59.9B | Healthcare |
| 21 | WUXI XDC CAYMAN INC | 2268.HK | 1.25% | $996,349 | 144,000 | 42.2 | $71.8B | Healthcare |
| 22 | REMEGEN CO LTD-H | 9995.HK | 1.23% | $985,434 | 81,000 | 94.5 | $50.3B | Healthcare |
| 23 | SICHUAN KELUN PHARMACEUTIC-A | 002422.SZ | 1.23% | $985,171 | 203,015 | 31.1 | $53.0B | Healthcare |
| 24 | SHANGHAI FOSUN PHARMACEUTI-A | 600196.SS | 1.21% | $967,779 | 264,329 | 19.9 | $66.9B | Healthcare |
| 25 | XTALPI HOLDINGS LTD | 2228.HK | 1.14% | $907,717 | 743,000 | -157.5 | $39.1B | Healthcare |
| 26 | HAISCO PHARMACEUTICAL GROU-A | 002653.SZ | 1.11% | $887,534 | 118,600 | 191.5 | $56.9B | Healthcare |
| 27 | CHINA RESOURCES SANJIU MED-A | 000999.SZ | 1.10% | $882,908 | 209,111 | 13.8 | $47.4B | Healthcare |
| 28 | SHANGHAI PHARMACEUTICALS-A | 601607.SS | 1.08% | $866,006 | 349,812 | 10.9 | $61.2B | Healthcare |
| 29 | BEIJING WANTAI BIOLOGICAL-A | 603392.SS | 0.99% | $788,380 | 133,642 | -150.1 | $50.4B | Healthcare |
| 30 | IMEIK TECHNOLOGY DEVELOPME-A | 300896.SZ | 0.97% | $771,718 | 38,340 | 27.8 | $37.0B | Healthcare |
| 31 | SHANGHAI ALLIST PHARMACEUT-A | 688578.SS | 0.95% | $761,254 | 57,150 | 19.0 | $41.7B | Healthcare |
| 32 | BEIJING TONG REN TANG CO-A | 600085.SS | 0.94% | $749,135 | 173,090 | 28.9 | $39.2B | Healthcare |
| 33 | GENSCRIPT BIOTECH CORP | 1548.HK | 0.93% | $742,375 | 516,000 | -5.7 | $24.1B | Healthcare |
| 34 | SHANGHAI RAAS BLOOD PRODUC-A | 002252.SZ | 0.92% | $735,397 | 829,034 | 21.1 | $38.9B | Healthcare |
| 35 | PHARMARON BEIJING CO LTD-A | 300759.SZ | 0.91% | $726,996 | 186,875 | 30.1 | $38.6B | Healthcare |
| 36 | SHENZHEN NEW INDUSTRIES BI-A | 300832.SZ | 0.90% | $715,581 | 98,700 | 23.5 | $39.2B | Healthcare |
| 37 | CHONGQING ZHIFEI BIOLOGICA-A | 300122.SZ | 0.88% | $702,838 | 304,972 | -26.7 | $36.2B | Healthcare |
| 38 | JIANGSU YUYUE MEDICAL EQU-A | 002223.SZ | 0.83% | $665,779 | 129,610 | 19.3 | $34.5B | Healthcare |
| 39 | GUANGZHOU BAIYUNSHAN PHAR-A | 600332.SS | 0.81% | $643,911 | 176,150 | 12.5 | $37.8B | Healthcare |
| 40 | CHANGCHUN HIGH-TECH INDUST-A | 000661.SZ | 0.81% | $648,752 | 50,308 | 35.9 | $35.0B | Healthcare |
| 41 | SHANDONG WEIGAO GP MEDICAL-H | 1066.HK | 0.79% | $634,174 | 1,077,600 | 9.2 | $20.2B | Healthcare |
| 42 | HEBEI CHANGSHAN BIOCHEMICA-A | 300255.SZ | 0.79% | $630,707 | 113,200 | -111.7 | $33.9B | Healthcare |
| 43 | APT MEDICAL INC-A | 688617.SS | 0.77% | $615,690 | 18,153 | 41.3 | $33.3B | Healthcare |
| 44 | CSPC INNOVATION PHARMACEUT-A | 300765.SZ | 0.73% | $586,997 | 127,957 | -165.3 | $41.7B | Consumer Defensive |
| 45 | LEGEND BIOTECH CORP-ADR | LEGN | 0.71% | $563,584 | 31,538 | -10.9 | $3.3B | Healthcare |
| 46 | HANGZHOU TIGERMED CONSULTI-A | 300347.SZ | 0.43% | $346,733 | 46,750 | 72.3 | $37.2B | Healthcare |
| 47 | Cash Cash | 0.11% | $84,247 | 84,247 | — | — | — | |
| 48 | HONG KONG DOLLAR Private | —% | $91 | 715 | — | — | — | |
| 49 | KANGMEI PHARMA - RIGHTS O Deriv | —% | — | 103,989 | — | — | — |